Ohio venture firm offers $30M in innovation funding
Rev1 Ventures, which announced Catalyst Fund III to invest in innovative life sciences companies, is a beneficial partner for startups and founders in the Great Lakes region, according to Ryan Helon, EVP.
Want to get more stories like this
one? Get daily news updates from Healthcare IT News.
Most Read
Research
White Papers
Patient Engagement
Patient Engagement
Financial/Revenue Cycle Management
Webinars
Artificial Intelligence
